A subset of MAPT mutations have been identified, such as IVS10+16, that result in phenotypes that are more clinically similar to PSP or CBD, which are generally considered sporadic diseases [24]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.